Structure Therapeutics Stock Forecast - Naive Prediction

GPCR Stock   88.64  3.62  4.26%   
The Naive Prediction forecasted value of Structure Therapeutics American on the next trading day is expected to be 101.38 with a mean absolute deviation of 4.33 and the sum of the absolute errors of 264.38. Structure Stock Forecast is based on your current time horizon. Although Structure Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Structure Therapeutics' systematic risk associated with finding meaningful patterns of Structure Therapeutics fundamentals over time.
The RSI of Structure Therapeutics' share price is above 70 as of today. This usually indicates that the stock is becoming overbought or overvalued. The idea behind Relative Strength Index (RSI) is that it helps to track how fast people are buying or selling Structure, making its price go up or down.

Momentum 71

 Buy Stretched

 
Oversold
 
Overbought
The successful prediction of Structure Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Structure Therapeutics and does not consider all of the tangible or intangible factors available from Structure Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Structure Therapeutics American, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Structure Therapeutics' stock price prediction:
EPS Estimate Next Quarter
(0.02)
EPS Estimate Current Year
(1.37)
EPS Estimate Next Year
(1.38)
Wall Street Target Price
101.7857
EPS Estimate Current Quarter
(0.37)
Using Structure Therapeutics hype-based prediction, you can estimate the value of Structure Therapeutics American from the perspective of Structure Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Structure Therapeutics using Structure Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Structure using crowd psychology based on the activity and movement of Structure Therapeutics' stock price.

Structure Therapeutics Short Interest

An investor who is long Structure Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Structure Therapeutics and may potentially protect profits, hedge Structure Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA
30.1826
Short Percent
0.1141
Short Ratio
2.66
Shares Short Prior Month
4.9 M
50 Day MA
53.7981

Structure Therapeutics Hype to Price Pattern

Investor biases related to Structure Therapeutics' public news can be used to forecast risks associated with an investment in Structure. The trend in average sentiment can be used to explain how an investor holding Structure can time the market purely based on public headlines and social activities around Structure Therapeutics American. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Structure Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Structure Therapeutics.

Structure Therapeutics Implied Volatility

    
  1.25  
Structure Therapeutics' implied volatility exposes the market's sentiment of Structure Therapeutics American stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Structure Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Structure Therapeutics stock will not fluctuate a lot when Structure Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Structure Therapeutics American on the next trading day is expected to be 101.38 with a mean absolute deviation of 4.33 and the sum of the absolute errors of 264.38.

Structure Therapeutics after-hype prediction price

    
  USD 88.64  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Structure Therapeutics to cross-verify your projections.
As of 01/18/2026, Payables Turnover is likely to drop to 0.01. As of 01/18/2026, Common Stock Shares Outstanding is likely to drop to about 43.8 M. In addition to that, Net Loss is likely to drop to about (41.4 M).

Open Interest Against 2026-04-17 Structure Option Contracts

Although open interest is a measure utilized in the options markets, it could be used to forecast Structure Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Structure Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Structure Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Structure Therapeutics' open interest, investors have to compare it to Structure Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Structure Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Structure. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.

Structure Therapeutics Additional Predictive Modules

Most predictive techniques to examine Structure price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Structure using various technical indicators. When you analyze Structure charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Structure Therapeutics Cash Forecast

Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Structure Therapeutics' financial statements to estimate their effects on upcoming price movements.
 
Cash  
First Reported
2010-12-31
Previous Quarter
194.9 M
Current Value
98.4 M
Quarterly Volatility
61.2 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
A naive forecasting model for Structure Therapeutics is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Structure Therapeutics American value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Structure Therapeutics Naive Prediction Price Forecast For the 19th of January

Given 90 days horizon, the Naive Prediction forecasted value of Structure Therapeutics American on the next trading day is expected to be 101.38 with a mean absolute deviation of 4.33, mean absolute percentage error of 36.25, and the sum of the absolute errors of 264.38.
Please note that although there have been many attempts to predict Structure Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Structure Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Structure Therapeutics Stock Forecast Pattern

Backtest Structure TherapeuticsStructure Therapeutics Price PredictionBuy or Sell Advice 

Structure Therapeutics Forecasted Value

In the context of forecasting Structure Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Structure Therapeutics' downside and upside margins for the forecasting period are 87.85 and 114.91, respectively. We have considered Structure Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
88.64
101.38
Expected Value
114.91
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Structure Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Structure Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria121.7009
BiasArithmetic mean of the errors None
MADMean absolute deviation4.3341
MAPEMean absolute percentage error0.0994
SAESum of the absolute errors264.3782
This model is not at all useful as a medium-long range forecasting tool of Structure Therapeutics American. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Structure Therapeutics. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Structure Therapeutics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Structure Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Structure Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
75.1188.64102.17
Details
Intrinsic
Valuation
LowRealHigh
57.3870.9197.50
Details
Bollinger
Band Projection (param)
LowMiddleHigh
55.1671.6188.05
Details
14 Analysts
Consensus
LowTargetHigh
92.62101.79112.98
Details

Other Forecasting Options for Structure Therapeutics

For every potential investor in Structure, whether a beginner or expert, Structure Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Structure Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Structure. Basic forecasting techniques help filter out the noise by identifying Structure Therapeutics' price trends.

Structure Therapeutics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Structure Therapeutics stock to make a market-neutral strategy. Peer analysis of Structure Therapeutics could also be used in its relative valuation, which is a method of valuing Structure Therapeutics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Structure Therapeutics Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Structure Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Structure Therapeutics' current price.

Structure Therapeutics Market Strength Events

Market strength indicators help investors to evaluate how Structure Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Structure Therapeutics shares will generate the highest return on investment. By undertsting and applying Structure Therapeutics stock market strength indicators, traders can identify Structure Therapeutics American entry and exit signals to maximize returns.

Structure Therapeutics Risk Indicators

The analysis of Structure Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Structure Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting structure stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Pair Trading with Structure Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Structure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Structure Stock

  0.65DMAC DiaMedica TherapeuticsPairCorr

Moving against Structure Stock

  0.79DRMA Dermata TherapeuticsPairCorr
  0.66RAC Race OncologyPairCorr
  0.61VANI Vivani MedicalPairCorr
  0.61AVH Avita MedicalPairCorr
  0.6CMB Cambium BioPairCorr
The ability to find closely correlated positions to Structure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Structure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Structure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Structure Therapeutics American to buy it.
The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Structure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Structure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Structure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Structure Stock Analysis

When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.